Jun 16, 2022 · 34m · how-i-built-this
HIBT Lab! Mark Cuban Cost Plus Drug Company: Mark Cuban
0:00 / 0:00
gold bands on the timeline = statements, start to end. Hover to read, click to jump. CC turns on captions
In this episode of 'How I Built This Lab,' Guy Raz interviews Mark Cuban about launching the Mark Cuban Cost Plus Drug Company to disrupt predatory prescription drug pricing through radical transparency, alongside discussions on emerging technologies and mission-driven investing.
How this conversation actually went
Every chapter scored 0–10 on four independent dynamics. Hover any point for the reasoning behind the score. Guy holds 30.1% of the talking time here. How this is scored →
Guy as informed peer 2.4 Guest teaching 3.4 Guest disagreement 1.6 Guy pushing back 1.6
speaking balance: gold is Guy, purple is the guest (3 minute bins)
Sharpest disagreement ▶ 30:13 Refusal to impose philanthropic duties on billionaires
Cuban explicitly dismisses Raz's normative question about billionaire obligations, refusing to pass judgment on figures like Musk and Bezos.
Hardest push from Guy ▶ 20:10 Raz presses Cuban on the billionaire-only barrier to entryRaz directly challenges Cuban's business narrative by asserting that the model only functions because Cuban is a rich individual indifferent to profit.
Biggest teaching moment ▶ 14:59 Cuban exposes the PBM and rebate ecosystemCuban thoroughly dismantles the conventional pharma R&D defense, educating Raz on how vertical integration and rebates drive up consumer costs.
Guy holds their own ▶ 8:10 Raz flawlessly summarizes Section 230 immunityRaz interrupts with a precise definition of Section 230 platform immunity, prompting Cuban to commend it as the most succinct summary he has ever heard.
the scores for every segment, with the reasoning behind each
| Chapter | Topic | Guy as informed peer | Guest teaching | Guest disagreement | Guy pushing back | Why |
|---|---|---|---|---|---|---|
| Mark Cuban on NFTs, Smart Contracts, and Digital Collectibles | 1 | 3 | 1 | 1 | Guy Raz sets up broad exploratory prompts about Mark Cuban's interest in cryptocurrency and NFTs. Cuban takes control of the floor to explain the mechanics of smart contracts, minting, and digital collectibles without friction. | |
| Delegation, Time Management, and Testing Ideas on Social Media | 4 | 1 | 1 | 1 | Guy Raz demonstrates sharp understanding by succinctly summarizing Section 230, which Cuban openly applauds. The segment focuses collaboratively on Cuban's habits of testing his arguments on social media. | |
| The Origin of Mark Cuban Cost Plus Drug Company | 2 | 3 | 0 | 0 | Raz asks Cuban to narrate the genesis of Cost Plus Drugs following an email from Dr. Alex Oshmiansky. Cuban provides a standard, cooperative storytelling response about Daraprim and market dynamics. | |
| Demystifying Drug Pricing and Exposing Pharmacy Benefit Managers | 3 | 6 | 2 | 2 | When Raz asks whether R&D costs justify high drug prices, Cuban reframes it as only half true and delivers an in-depth breakdown of how pharmacy benefit managers and vertical integration game Medicare pricing. | |
| Public Benefit Structure, Dallas Facility, and Industry Competition | 3 | 4 | 2 | 3 | Raz pushes Cuban with sharp business questions about why TruePill would not replicate the model and whether only billionaires can pursue this strategy. Cuban explains the economics of public benefit corporations and their robotic plant. | |
| Scaling Challenges, Supply Bottlenecks, and PBM Pushback | 2 | 5 | 2 | 2 | Raz inquires about production bottlenecks and insulin, prompting Cuban to clarify that drug manufacturers are often willing but are bullied by PBM formulary threats. | |
| Philanthropic Capital, Technological Impact, and Future Investments | 2 | 2 | 3 | 2 | Raz pushes a normative question about whether the ultra-wealthy have an obligation to fund social solutions. Cuban rejects the moralizing premise, defending diverse pursuits like space travel before outlining his investments in DAOs and AI education. |
Statements from this episode (19)
Cuban: Smart contracts are Web3's equivalent to HTML and JavaScript
“Smart contracts really are just a programming language that are probably the equivalent of HTML or JavaScript for creating a website. Only these run on a decentralized distributed basis on top of a blockchain.”
Cuban: I am not involved in the day-to-day operations of any business
“Now, I don't, I'm not really involved in day-to-day operations of anything.”
Cuban: Algorithmic content promotion is effectively an editorial choice
“Because when you're
Designing an algorithm or using AI and setting the goals of the AI that you've created, the neural networks you've created, you effectively are making an editorial choice to promote something.”
Cuban has invested $100M+ into founders he has never met
“Believe it or not, I've probably invested over a hundred million dollars into people I've never met in my entire life from cold emails or cold calls or whatever it may be and done really well with those investments.”
Cuban: Cost Plus Drugs will offer 2,000 medications by year-end
“And by the end of the year, we'll be up to 2000.”
Cuban: Vertically integrated healthcare firms and PBMs manipulate drug pricing
“The way the drug industry is now, the process that takes a drug, once it's been manufactured, put aside all their R&D and the development of the trials, Once that drug manufacturer starts making a drug, the process it has to go through to get to the patients i…”
Cost Plus Drugs charges a 15% markup, plus $3 handling and $5 shipping
“So if you go to costplusdrugs.com, put in the name of the drug, and if we carry it, we'll show you our cost. Right. And then we will show you our markup, which is 15%, Then we charge three dollars for handling through our pharmacy partner, TruePill, and five d…”
Cuban: Cost Plus Drugs prices are almost always lower than insurance copays
“All the complications that are introduced by these pharmacy benefit managers and the big companies that they are part of, we eliminate, and that allows us to sell our drugs almost always for less than the copay that you have for your insurance.”
Cuban: Any $100M profit will fund new drug manufacturing or price cuts
“If it looked like I was making a hundred million dollars a year, I would either invest that in creating a new, you know, manufacturing existing drugs that I can get a license to, or I would lower my prices some more.”
Cuban: Cost Plus Drugs is the first company bearing my name
“I've never put my name on a company until now.”
Cost Plus Drugs is building a robotics-driven pharmaceutical plant in Dallas
“We're, you know, I mentioned we're spending a lot of money on a plant here in Dallas, and it's going to be driven by robotics so that we can go through and take any, a given pill and manufacture one year or two years worth of supply switch it over to another p…”
Cuban plans nationwide drug manufacturing facilities as Cost Plus volume grows
“No, we won't be able to, you know, it's not going to turn out a billion dollars worth of drugs each and every year, but it's a starting point for us.
And once we're able to establish enough volume, we'll be able to build another one, then another one, you know…”
Cuban: Drug manufacturers fear insurance company retaliation for supplying Cost Plus
“Part of the challenge is getting manufacturers to sell to us because they're afraid of the response they'll get from the insurance companies.”
Cuban: Mandating open drug distribution solves pricing problems better than regulation
“And when you hear all this talk about regulating prices of drugs by different politicians, they're not solving the problem.
They're creating different problems.
The reality is that the solution is, is trying to make sure that all these manufacturers sell not j…”
Cuban blames vertically integrated insurers, not manufacturers, for high insulin prices
“It's not the insulin manufacturers for the most part that are distorting everything.
It's the, these vertically integrated companies, not all are owned by insurance companies, but for the most part they are.”
Cuban: Cost Plus refuses to work with insurers that demand rebates
“Our mission is very straightforward.
We want to be the low cost provider of every drug we sell.
And with that definition, we can't work with an insurance company that
Is going to require rebates or anything like that.”
Cuban: Cost Plus Drugs is self-funded, even if it cuts into inheritance
“This is kind of like the one thing I've said, okay, sorry kids. You know, your inheritance is going to maybe reduced if it doesn't work. Just because it's that important to me.”
Cuban: DAOs can align progressive and capitalist goals better than traditional unions
“There's these things called distributed autonomous organizations, DAO. Which I think can evolve to be the best of progressive goals of allowing workers to participate in all upside and capitalist goals where, you know, people who come up with great ideas using…”